TLR9 and cancer: DCs express a wide range of pattern-recognition receptors, among which TLR-3, TLR-4 and TLR-9 are good candidates as adjuvant targets to elicit potent cytotoxic T cell responses in mice and humans for cancer as well as infectious disease vaccination25, 26, 27, 28, 29.